Literature DB >> 11485397

Crystallization of Brome mosaic virus and T = 1 Brome mosaic virus particles following a structural transition.

R W Lucas1, Y G Kuznetsov, S B Larson, A McPherson.   

Abstract

Brome mosaic virus (BMV), a T = 3 icosahedral plant virus, can be dissociated into coat protein subunits and subunit oligomers at pH 7.5 in the presence of concentrated salts. We have found that during the course of this treatment the coat protein subunits are cleaved, presumably by plant cell proteases still present in the preparation, between amino acids 35 and 36. The truncated protein subunits will then reorganize into T = 1 icosahedral particles and can be crystallized from sodium malonate. Quasi elastic light scattering and atomic force microscopy results suggest that the transition from T = 3 to T = 1 particles can occur by separate pathways, dissociation into coat protein subunits and oligomers and reassembly into T = 1 particles, or direct condensation of the T = 3 virions to T = 1 particles with the shedding of hexameric capsomeres. The latter process has been directly visualized using atomic force microscopy. Native T = 3 virions have been crystallized in several different crystal forms, but neither a rhombohedral form nor either of two orthorhombic forms diffract beyond about 3.4 A. Tetragonal crystals of the T = 1 particles, however, diffract to at least 2.5 A resolution. Evidence suggests that the T = 1 particles are more structurally uniform and ordered than are native T = 3 virions. A variety of anomalous virus particles having diverse sizes have been visualized in preparations of BMV used for crystallization. In some cases these aberrant particles are incorporated into growing crystals where they are frequently responsible for defect formation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11485397     DOI: 10.1006/viro.2000.0897

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Core-controlled polymorphism in virus-like particles.

Authors:  Jingchuan Sun; Chris DuFort; Marie-Christine Daniel; Ayaluru Murali; Chao Chen; Kodetham Gopinath; Barry Stein; Mrinmoy De; Vincent M Rotello; Andreas Holzenburg; C Cheng Kao; Bogdan Dragnea
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

Review 2.  Atomic force microscopy in imaging of viruses and virus-infected cells.

Authors:  Yurii G Kuznetsov; Alexander McPherson
Journal:  Microbiol Mol Biol Rev       Date:  2011-06       Impact factor: 11.056

Review 3.  Imaging modes of atomic force microscopy for application in molecular and cell biology.

Authors:  Yves F Dufrêne; Toshio Ando; Ricardo Garcia; David Alsteens; David Martinez-Martin; Andreas Engel; Christoph Gerber; Daniel J Müller
Journal:  Nat Nanotechnol       Date:  2017-04-06       Impact factor: 39.213

Review 4.  The coat protein leads the way: an update on basic and applied studies with the Brome mosaic virus coat protein.

Authors:  C Cheng Kao; Peng Ni; Masarapu Hema; Xinlei Huang; Bogdan Dragnea
Journal:  Mol Plant Pathol       Date:  2010-11-25       Impact factor: 5.663

5.  A New and Efficient Poisson-Boltzmann Solver for Interaction of Multiple Proteins.

Authors:  Eng-Hui Yap; Teresa Head-Gordon
Journal:  J Chem Theory Comput       Date:  2010-06-17       Impact factor: 6.006

6.  Birth and growth kinetics of brome mosaic virus microcrystals.

Authors:  Marina Casselyn; Annette Tardieu; Hervé Delacroix; Stéphanie Finet
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

7.  Induction of particle polymorphism by cucumber necrosis virus coat protein mutants in vivo.

Authors:  Kishore Kakani; Ron Reade; Umesh Katpally; Thomas Smith; D'Ann Rochon
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

8.  Atomic force microscopy investigation of human immunodeficiency virus (HIV) and HIV-infected lymphocytes.

Authors:  Y G Kuznetsov; J G Victoria; W E Robinson; A McPherson
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.